Long-term treatment of refractory invasive fungal infection with posaconazole: additive value of therapeutic drug monitoring.
Posaconazole is a recently developed broad-spectrum triazole antifungal with potential for long-term prophylaxis or therapy of invasive fungal infections. This case illustrates the additive value for therapeutic drug monitoring to guide clinical decision-making in high risk patients.